Source comparison
Dosing Protocols: Single vs Multi-Dose Strategies
The standard research range for Hexarelin fat loss studies spans 100–300mcg total daily dose. How that dose is distributed determines efficacy more than total volume. Single daily administrations above 200mcg produce higher peak GH levels (8–12× baseline) but
This comparison does not assign a generated winner or score.
- The standard research range for Hexarelin fat loss studies spans 100–300mcg total daily dose. How that dose is distributed determines efficacy more than total volume. Single daily administrations above 200mcg produce higher peak GH levels (8–12× baseline) but trigger ghrelin receptor desensitization within 7–10 days, reducing subsequent GH responses by 40–60%. Multi-dose protocols using 100mcg three times daily maintain moderate GH elevation (4–6× baseline per pulse) across 8–12 week study periods without significant receptor downregulation.
- Timing matters as much as frequency. Administering Hexarelin on an empty stomach. Minimum 2 hours post-meal, 30 minutes pre-meal. Maximizes GH release by preventing insulin and glucose from blunting the secretagogue effect. Insulin elevations above 10 μIU/mL can reduce Hexarelin-induced GH secretion by 50–70%. Our team has found that researchers who administer doses immediately upon waking, mid-afternoon (4–6 hours post-lunch), and 90 minutes pre-sleep achieve the most consistent fat loss markers across study cohorts.
- The three-dose protocol follows this structure: 100mcg upon waking (fasted), 100mcg at 2–3 PM (minimum 3 hours post-lunch), 100mcg 60–90 minutes before sleep. The pre-sleep dose capitalizes on endogenous nocturnal GH secretion, amplifying the natural pulse rather than replacing it. Studies show this timing produces 25–30% greater overnight lipolysis compared to morning-only dosing.
- Two-dose protocols work for researchers prioritizing convenience over maximum effect: 150mcg upon waking, 150mcg pre-sleep. This maintains pulsatile signaling without midday administration but sacrifices the afternoon lipolytic window. Total daily exposure remains 300mcg, but the longer inter-dose interval (12–14 hours) allows partial receptor recovery between pulses.
- One critical constraint: exceeding 200mcg per individual dose shifts the GH response curve into a zone where cortisol co-release becomes disproportionate. A 300mcg single dose doesn't produce 3× the GH of a 100mcg dose. It produces approximately 1.8× the GH alongside 2.5× the cortisol elevation. The math doesn't favor single high-dose protocols for fat loss endpoints.